COVID-19 Boosters, Third Doses Well Tolerated Among Pregnant, Lactating People
Pregnant people less likely to report systemic reactions than lactating individuals.
COVID19 Vaccine
COVID-19 Vaccination Does Not Negatively Impact Fertility
Findings seen for women undergoing in vitro fertilization-fresh embryo transfer cycle.
Certain Blood Cancer Patients Do Not Seroconvert After a Third COVID-19 Vaccine Dose
Seroconversion rates were low for patients receiving anti-CD20 therapy, CAR T-cell therapy, and transplants, as well as CLL patients taking ibrutinib.
FDA Authorizes Use of Novavax COVID-19 Vaccine, Adjuvanted in Adolescents
The FDA has expanded the EUA for the Novavax COVID-19 Vaccine, Adjuvanted to include adolescents 12 to 17 years of age to prevent COVID-19.
Vaccination Cuts Risk for Myocardial Infarction, Stroke After COVID-19
Findings show lower hospitalization risk 31 to 120 days after COVID-19 infection.
Third Dose of COVID-19 Vaccine Appears Least Effective for Lymphoma Patients
Vaccine effectiveness against breakthrough SARS-CoV-2 infections was 10.5% for patients with lymphoma.
SARS-CoV-2-Linked Hospitalization, ED Encounters Rare After Paxlovid
<1 percent of patients to whom Paxlovid was dispensed for mild-to-moderate COVID-19 had hospitalization or ED encounter.
Fourth Dose of BNT162b2 Prevents Severe COVID-19 in Nursing Home Residents
Substantial protection against hospitalizations, deaths seen among long-term care facility residents during omicron surge.
Vaccines Estimated to Have Prevented 19.8 Million COVID-19 Deaths
More deaths would have been averted had vaccine coverage targets from COVAX and WHO been met.
Flow Cytometry-Based Method of Diagnosis Developed for Vaccine-Induced Immune Thrombotic Thrombocytopenia
Researchers sought to determine whether an assay using flow cytometry may help to diagnose patients who have vaccine-induced immune thrombotic thrombocytopenia.
- Loading...
Loading...
Next post in Thrombotic Disorders
Loading... 
Loading...